1. Home
  2. PMN vs SPCB Comparison

PMN vs SPCB Comparison

Compare PMN & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMN
  • SPCB
  • Stock Information
  • Founded
  • PMN 2004
  • SPCB 1988
  • Country
  • PMN Canada
  • SPCB Israel
  • Employees
  • PMN N/A
  • SPCB N/A
  • Industry
  • PMN Pharmaceuticals and Biotechnology
  • SPCB Semiconductors
  • Sector
  • PMN Health Care
  • SPCB Technology
  • Exchange
  • PMN Nasdaq
  • SPCB Nasdaq
  • Market Cap
  • PMN 29.8M
  • SPCB 31.4M
  • IPO Year
  • PMN N/A
  • SPCB N/A
  • Fundamental
  • Price
  • PMN $0.82
  • SPCB $10.77
  • Analyst Decision
  • PMN
  • SPCB Strong Buy
  • Analyst Count
  • PMN 0
  • SPCB 1
  • Target Price
  • PMN N/A
  • SPCB $18.00
  • AVG Volume (30 Days)
  • PMN 44.3K
  • SPCB 409.8K
  • Earning Date
  • PMN 03-31-2025
  • SPCB 11-14-2024
  • Dividend Yield
  • PMN N/A
  • SPCB N/A
  • EPS Growth
  • PMN N/A
  • SPCB N/A
  • EPS
  • PMN N/A
  • SPCB 1.02
  • Revenue
  • PMN N/A
  • SPCB $26,843,000.00
  • Revenue This Year
  • PMN N/A
  • SPCB $6.72
  • Revenue Next Year
  • PMN N/A
  • SPCB $16.91
  • P/E Ratio
  • PMN N/A
  • SPCB $10.55
  • Revenue Growth
  • PMN N/A
  • SPCB 5.23
  • 52 Week Low
  • PMN $0.80
  • SPCB $2.55
  • 52 Week High
  • PMN $2.61
  • SPCB $18.95
  • Technical
  • Relative Strength Index (RSI)
  • PMN 36.19
  • SPCB 51.88
  • Support Level
  • PMN $0.81
  • SPCB $10.50
  • Resistance Level
  • PMN $0.94
  • SPCB $13.69
  • Average True Range (ATR)
  • PMN 0.07
  • SPCB 1.25
  • MACD
  • PMN -0.01
  • SPCB -0.17
  • Stochastic Oscillator
  • PMN 6.07
  • SPCB 41.25

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.

Share on Social Networks: